Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00098436
Status:
COMPLETED
Last Update Posted:
2013-07-18
First Post:
2004-12-07
Brief Title:
Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias
Sponsor:
Vion Pharmaceuticals
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
Keywords:
| Name | View |
|---|---|
| adult acute myeloid leukemia with t821q22q22 | View |
| recurrent adult acute myeloid leukemia | View |
| recurrent adult acute lymphoblastic leukemia | View |
| blastic phase chronic myelogenous leukemia | View |
| relapsing chronic myelogenous leukemia | View |
| secondary acute myeloid leukemia | View |
| adult acute myeloid leukemia with 11q23 MLL abnormalities | View |
| adult acute myeloid leukemia with inv16p13q22 | View |
| adult acute myeloid leukemia with t1517q22q12 | View |
| adult acute myeloid leukemia with t1616p13q22 | View |